PMID: 3383959Mar 1, 1988Paper

Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections

European Journal of Cancer & Clinical Oncology
J P SculierJ Klastersky

Abstract

A pilot study with amphotericin B incorporated in sonicated liposomes (ampholiposomes) made of egg phosphatidylcholine, cholesterol and stearylamine in a molar ratio 4:3:1 was performed in cancer patients with fungal infections. Fifteen patients received a total of 117 intravenous infusions of ampholiposomes. The total dose of amphotericin B administered per patient ranged from 20 to 1004 mg (mean 472 mg). The number of infusions per patient varied from 1 to 20 (mean 8) and the duration of treatment from 1 to 29 days (mean 10 days). Infusion of doses up to 1.8 mg/kg was well tolerated. None of the common side-effects of Fungizone, the colloidal suspension of amphotericin B, occurred; it was noteworthy that patients had no renal function impairment. Serum amphotericin B concentrations given as ampholiposomes were much higher than those obtained with Fungizone. With a daily treatment schedule, peak and trough serum amphotericin B concentrations, as measured by HPLC, were 10 to 20 micrograms/ml and 5 to 10 micrograms/ml respectively; while they did not exceed 2 micrograms/ml and 1 microgram/ml with Fungizone. Amphotericin B given as ampholiposomes had a prolonged serum beta half-life (25.3 +/- 16.0 h). Higher serum antifungal acti...Continue Reading

References

Feb 1, 1978·Antimicrobial Agents and Chemotherapy·A J Atkinson, J E Bennett
Jan 1, 1977·Antimicrobial Agents and Chemotherapy·S H LinG S Kobayashi
May 1, 1977·Annals of Internal Medicine·J AisnerS C Schimpff
Feb 1, 1986·European Journal of Clinical Microbiology·F Meunier
Aug 7, 1987·Journal of Chromatography·C BrassinneF Meunier
May 1, 1985·Antimicrobial Agents and Chemotherapy·P C Craven, D H Gremillion
Jan 1, 1985·Cancer Drug Delivery·G Lopez-BeresteinK Mehta
Dec 5, 1985·The New England Journal of Medicine·K Godfrey
Oct 1, 1969·The Journal of Infectious Diseases·D D Bindschadler, J E Bennett
Mar 1, 1984·Antimicrobial Agents and Chemotherapy·R L HopferR L Juliano
Aug 1, 1984·Antimicrobial Agents and Chemotherapy·C TremblayF Szoka
Aug 1, 1984·The Journal of Infectious Diseases·G Lopez-BeresteinR L Juliano
Jan 17, 1980·The New England Journal of Medicine·G Medoff, G S Kobayashi
May 1, 1982·The Journal of Infectious Diseases·J R GraybillW E Magee
May 1, 1982·The American Review of Respiratory Disease·R L TaylorW E Magee
Aug 1, 1982·The Journal of Infectious Diseases·W G EllisS L Nielsen
Oct 1, 1982·The American Journal of Medicine·M W DeGregorioC A Ries
Nov 1, 1981·The Journal of Antimicrobial Chemotherapy·R R NewS Heath

❮ Previous
Next ❯

Citations

Jan 1, 1995·Cancer Chemotherapy and Pharmacology·L Beketic-Oreskovic, M Osmak
Jan 1, 1993·Journal of Cancer Research and Clinical Oncology·P C GokhaleS K Pandya
Oct 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J P SculierF Meunier
Mar 1, 1989·Infectious Disease Clinics of North America·M A Crislip, J E Edwards
Jan 1, 1991·Biotherapy·H G Eichler
Jul 1, 1996·Pharmaceutica acta Helvetiae·M C Venier-Julienne, J P Benoît
Feb 13, 2001·International Journal of Pharmaceutics·T EldemE Kansu
May 9, 2002·International Journal of Pharmaceutics·Rajshree N KotwaniSunil K Pandya
Dec 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·D PapahadjopoulosC Redemann
Jan 1, 1993·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·M Y LevyS Benita
Aug 1, 1991·Journal of Internal Medicine·M BjörkholmA M Udén
Mar 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff
Apr 1, 1991·Antimicrobial Agents and Chemotherapy·J M ClarkD P Bonner
Dec 1, 1992·Antimicrobial Agents and Chemotherapy·L Saint-JulienP Yeni
Apr 1, 1993·The British Journal of Ophthalmology·Y OguraR Zeimer
Mar 15, 2000·Journal of the American Veterinary Medical Association·A N Plotnick
Jan 1, 1991·Cancer Investigation·F Meunier
Sep 1, 1994·Journal of the American Academy of Dermatology·R J Hay
May 1, 1994·The Journal of Infection·R J Hay
Dec 1, 1989·European Journal of Cancer & Clinical Oncology·A GabizonY Barenholz
Jan 1, 1994·Journal of Drug Targeting·I A Bakker-WoudenbergM C Woodle
Jan 1, 1993·Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology·P LegrandJ Bolard
Apr 9, 1998·Journal of Microencapsulation·M GulatiM Singh
Apr 1, 1993·Journal of Microencapsulation·M SinghH Atwal
Jun 1, 1991·Japanese Journal of Cancer Research : Gann·T MorikageN Saijo
Jun 14, 2006·Advances in Colloid and Interface Science·Suzana Segota, Durdica Tezak
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J P SculierJ Schmerber
Jan 1, 1996·Infection·H Hogevik, K Alestig
May 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F Meunier
Oct 9, 2020·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Mariana VoicescuLucia Moldovan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

© 2021 Meta ULC. All rights reserved